208 related articles for article (PubMed ID: 38307904)
1. Mutation-specific CAR T cells as precision therapy for IGLV3-21
Märkl F; Schultheiß C; Ali M; Chen SS; Zintchenko M; Egli L; Mietz J; Chijioke O; Paschold L; Spajic S; Holtermann A; Dörr J; Stock S; Zingg A; Läubli H; Piseddu I; Anz D; Minden MD; Zhang T; Nerreter T; Hudecek M; Minguet S; Chiorazzi N; Kobold S; Binder M
Nat Commun; 2024 Feb; 15(1):993. PubMed ID: 38307904
[TBL] [Abstract][Full Text] [Related]
2.
Maity PC; Bilal M; Koning MT; Young M; van Bergen CAM; Renna V; Nicolò A; Datta M; Gentner-Göbel E; Barendse RS; Somers SF; de Groen RAL; Vermaat JSP; Steinbrecher D; Schneider C; Tausch E; Bittolo T; Bomben R; Mazzarello AN; Del Poeta G; Kroes WGM; van Wezel JT; Imkeller K; Busse CE; Degano M; Bakchoul T; Schulz AR; Mei H; Ghia P; Kotta K; Stamatopoulos K; Wardemann H; Zucchetto A; Chiorazzi N; Gattei V; Stilgenbauer S; Veelken H; Jumaa H
Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4320-4327. PubMed ID: 32047037
[TBL] [Abstract][Full Text] [Related]
3. IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics.
Nadeu F; Royo R; Clot G; Duran-Ferrer M; Navarro A; Martín S; Lu J; Zenz T; Baumann T; Jares P; Puente XS; Martín-Subero JI; Delgado J; Campo E
Blood; 2021 May; 137(21):2935-2946. PubMed ID: 33211804
[TBL] [Abstract][Full Text] [Related]
4. 5' Rapid amplification of cDNA ends (5'RACE): A simpler method to analyze immunoglobulin genes and discover the value of the light chain in chronic lymphocytic leukemia.
Lan X; Ruminy P; Bohers E; Rainville V; Viennot M; Viailly PJ; Etancelin P; Tilly H; Mihailescu S; Bouclet F; Leprêtre S; Jardin F
Leuk Res; 2022 Dec; 123():106952. PubMed ID: 36272389
[TBL] [Abstract][Full Text] [Related]
5. CAR T cells Targeting Human Immunoglobulin Light Chains Eradicate Mature B-cell Malignancies While Sparing a Subset of Normal B Cells.
Ranganathan R; Shou P; Ahn S; Sun C; West J; Savoldo B; Dotti G
Clin Cancer Res; 2021 Nov; 27(21):5951-5960. PubMed ID: 33858858
[TBL] [Abstract][Full Text] [Related]
6. Identification of Distinct Unmutated Chronic Lymphocytic Leukemia Subsets in Mice Based on Their T Cell Dependency.
Pal Singh S; de Bruijn MJW; de Almeida MP; Meijers RWJ; Nitschke L; Langerak AW; Pillai SY; Stadhouders R; Hendriks RW
Front Immunol; 2018; 9():1996. PubMed ID: 30271400
[TBL] [Abstract][Full Text] [Related]
7. Consistent B Cell Receptor Immunoglobulin Features Between Siblings in Familial Chronic Lymphocytic Leukemia.
Kolijn PM; Muggen AF; Ljungström V; Agathangelidis A; Wolvers-Tettero ILM; Beverloo HB; Pál K; Hengeveld PJ; Darzentas N; Hendriks RW; van Dongen JJM; Rosenquist R; Langerak AW
Front Oncol; 2021; 11():740083. PubMed ID: 34513715
[TBL] [Abstract][Full Text] [Related]
8. The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia: Results of a Multicenter Study.
Stamatopoulos B; Smith T; Crompot E; Pieters K; Clifford R; Mraz M; Robbe P; Burns A; Timbs A; Bruce D; Hillmen P; Meuleman N; Mineur P; Firescu R; Maerevoet M; De Wilde V; Efira A; Philippé J; Verhasselt B; Offner F; Sims D; Heger A; Dreau H; Schuh A
Clin Cancer Res; 2018 Oct; 24(20):5048-5057. PubMed ID: 29945996
[No Abstract] [Full Text] [Related]
9. Chimeric antigen receptor T cells targeting Fc μ receptor selectively eliminate CLL cells while sparing healthy B cells.
Faitschuk E; Hombach AA; Frenzel LP; Wendtner CM; Abken H
Blood; 2016 Sep; 128(13):1711-22. PubMed ID: 27535994
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptor.
Giordano Attianese GM; Marin V; Hoyos V; Savoldo B; Pizzitola I; Tettamanti S; Agostoni V; Parma M; Ponzoni M; Bertilaccio MT; Ghia P; Biondi A; Dotti G; Biagi E
Blood; 2011 May; 117(18):4736-45. PubMed ID: 21406718
[TBL] [Abstract][Full Text] [Related]
11. Performance of anti-CD19 chimeric antigen receptor T cells in genetically defined classes of chronic lymphocytic leukemia.
Mancikova V; Peschelova H; Kozlova V; Ledererova A; Ladungova A; Verner J; Loja T; Folber F; Mayer J; Pospisilova S; Smida M
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217767
[TBL] [Abstract][Full Text] [Related]
12. The Determinants of B Cell Receptor Signaling as Prototype Molecular Biomarkers of Leukemia.
Nicolò A; Linder AT; Jumaa H; Maity PC
Front Oncol; 2021; 11():771669. PubMed ID: 34993136
[TBL] [Abstract][Full Text] [Related]
13. Exploiting B-cell Receptor Stereotypy to Design Tailored Immunotherapy in Chronic Lymphocytic Leukemia.
Rovida A; Maccalli C; Scarfò L; Dellabona P; Stamatopoulos K; Ghia P
Clin Cancer Res; 2021 Feb; 27(3):729-739. PubMed ID: 33051305
[TBL] [Abstract][Full Text] [Related]
14. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
Bomben R; Dal Bo M; Capello D; Forconi F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Zucchetto A; Bertoni F; Rossi FM; Bulian P; Cattarossi I; Ilariucci F; Sozzi E; Spina V; Zucca E; Degan M; Lauria F; Del Poeta G; Efremov DG; Marasca R; Gaidano G; Gattei V
Br J Haematol; 2009 Feb; 144(4):492-506. PubMed ID: 19036101
[TBL] [Abstract][Full Text] [Related]
15. The
Perez-Chacon G; Zapata JM
Front Immunol; 2021; 12():627602. PubMed ID: 33912159
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia.
Hadzidimitriou A; Darzentas N; Murray F; Smilevska T; Arvaniti E; Tresoldi C; Tsaftaris A; Laoutaris N; Anagnostopoulos A; Davi F; Ghia P; Rosenquist R; Stamatopoulos K; Belessi C
Blood; 2009 Jan; 113(2):403-11. PubMed ID: 18948572
[TBL] [Abstract][Full Text] [Related]
17. Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia.
Rossi D; Spina V; Bomben R; Rasi S; Dal-Bo M; Bruscaggin A; Rossi FM; Monti S; Degan M; Ciardullo C; Serra R; Zucchetto A; Nomdedeu J; Bulian P; Grossi A; Zaja F; Pozzato G; Laurenti L; Efremov DG; Di-Raimondo F; Marasca R; Forconi F; Del Poeta G; Gaidano G; Gattei V
Blood; 2013 Jun; 121(24):4902-5. PubMed ID: 23637131
[TBL] [Abstract][Full Text] [Related]
18. Higher-order immunoglobulin repertoire restrictions in CLL: the illustrative case of stereotyped subsets 2 and 169.
Gemenetzi K; Psomopoulos F; Carriles AA; Gounari M; Minici C; Plevova K; Sutton LA; Tsagiopoulou M; Baliakas P; Pasentsis K; Anagnostopoulos A; Sandaltzopoulos R; Rosenquist R; Davi F; Pospisilova S; Ghia P; Stamatopoulos K; Degano M; Chatzidimitriou A
Blood; 2021 Apr; 137(14):1895-1904. PubMed ID: 33036024
[TBL] [Abstract][Full Text] [Related]
19. The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling.
Lorenzo-Herrero S; Sordo-Bahamonde C; Bretones G; Payer ÁR; González-Rodríguez AP; González-García E; Pérez-Escuredo J; Villa-Álvarez M; Núñez LE; Morís F; Gonzalez S; López-Soto A
Front Immunol; 2019; 10():2455. PubMed ID: 31681329
[TBL] [Abstract][Full Text] [Related]
20. Driving Out Chronic Lymphocytic Leukemia With CAR T Cells.
Kharfan-Dabaja MA; Yassine F; Gadd ME; Qin H
Transplant Cell Ther; 2022 Jan; 28(1):5-17. PubMed ID: 34656807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
